diabetic retinopathy is a common and specific microvascular complication of diabetes and remains the leading cause of preventable blindness in workingaged peopleit is identified in a third of people with diabetes and associated with increased risk of lifethreatening systemic vascular complications including stroke coronary heart disease and heart failureoptimum control of blood glucose blood pressure and possibly blood lipids remains the foundation for reduction of risk of retinopathy development and progressiontimely laser therapy is effective for preservation of sight in proliferative retinopathy and macular oedema but its ability to reverse visual loss is poorvitrectomy surgery might occasionally be needed for advanced retinopathynew therapies such as intraocular injection of steroids and antivascular endothelial growthfactor agents are less destructive to the retina than are older therapies and could be useful in patients who respond poorly to conventional therapythe outlook for future treatment modalities such as inhibition of other angiogenic factors regenerative therapy and topical therapy is promisingcopyright 2010 elsevier ltd all rights reserved